Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders

Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders

A recent report showed that most pediatric cases of non-eosinophilic esophagitis (EoE) eosinophilic gastrointestinal disorders (EGIDs) (non-EoE EGIDs) are persistent and severe compared with those of EoE, thus requiring further effective therapeutic approaches. In this study, we present the first ca...

Full description

Bibliographic Details
Main Authors: Naoya Arakawa, Hisako Yagi, Mariko Shimizu, Daisuke Shigeta, Akihiko Shimizu, Shigeru Nomura, Takumi Takizawa, Yoshiyuki Yamada
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomolecules
Subjects:
dupilumab
biologic
eosinophil
eosinophilic gastrointestinal disorder (EGID)
non-eosinophilic esophagitis (EoE) eosinophilic gastrointestinal disorder (EGID) (non-EoE EGID)
elimination diet
Online Access:https://www.mdpi.com/2218-273X/13/1/112

Similar Items

Similar Items